India Launches Drug Registry to Standardize Medicine Data Across Healthcare Ecosystem : Dharmakshethra

Union Health Minister Shri Jagat Prakash Nadda has launched the Drug Registry, a unified and standardized digital platform designed to bring consistency, transparency and interoperability to medicine-related information across India’s healthcare ecosystem. The initiative has been conceptualized under the Ayushman Bharat Digital Mission and is expected to become a major building block in India’s expanding digital health infrastructure.

Medicines form one of the most critical data elements in healthcare delivery. Every prescription, pharmacy transaction, hospital record, insurance claim, clinical decision, drug inventory system and public health programme depends on accurate medicine information. However, India’s healthcare ecosystem has long faced a basic but serious data challenge: the same medicine may be recorded in different systems using different spellings, names, formats, brand references, generic references or manufacturer details.

This creates duplication, confusion and lack of interoperability across healthcare platforms. It can affect e-prescriptions, hospital information systems, pharmacy databases, supply chain systems, doctor-facing applications, insurance workflows and continuity of patient care. The Drug Registry has been introduced to address this gap by creating a single, verified and standardized source of drug information for the country.

Why the Drug Registry Matters

In healthcare, data standardization is not merely a technical requirement. It directly affects patient safety, clinical accuracy, medicine availability, prescription quality and the ability of hospitals and digital platforms to communicate with each other.

For example, a doctor may prescribe a medicine using a generic name. A pharmacy system may store it using a brand name. A hospital inventory system may classify it under a manufacturer-specific code. An insurance or claims platform may record the same medicine in another format. When these systems cannot identify that they are referring to the same medicine or substance, data errors and inefficiencies emerge.

The Drug Registry aims to solve this problem by assigning standardized drug codes and structured medicine information. This allows different healthcare systems to recognize the same medicine in a consistent way.

The initiative is especially important as India moves deeper into digital health. E-prescriptions, digital health records, telemedicine, electronic medical records, hospital management systems, insurance claim platforms and public health dashboards all require standardized medicine data. A national drug registry can act as the common language connecting these systems.

Drug Registry Under Ayushman Bharat Digital Mission

The Drug Registry has been developed as part of the Ayushman Bharat Digital Mission. ABDM is creating India’s digital health ecosystem through core registries and interoperable digital standards.

The four major ABDM registries are:

ABHA Registry for individuals.

Healthcare Professional Registry for verified healthcare professionals.

Health Facility Registry for verified hospitals, clinics, laboratories and other healthcare facilities.

Drug Registry for medicines.

Together, these registries form the backbone of a connected digital health system. ABHA helps identify individuals. HPR helps identify healthcare professionals. HFR helps identify healthcare facilities. The Drug Registry helps identify medicines.

This structure allows a digital health transaction to become more complete and reliable. A prescription, for instance, can be linked to a verified patient, issued by a verified doctor, generated from a verified health facility and mapped to standardized medicine information.

Developed With CDSCO and NRCeS

The Drug Registry has been developed in collaboration with the Central Drugs Standard Control Organization and the National Resource Centre for EHR Standards, Pune.

CDSCO’s involvement is significant because it is India’s national regulatory authority for drugs and medical devices. Its role strengthens the regulatory credibility of the registry.

NRCeS Pune’s role is also important because electronic health record standards require semantic consistency. In simple terms, digital health systems must not only exchange data, but also understand the meaning of that data. When one system sends a drug name or code to another system, the receiving system must interpret it correctly. This is where health data standards become crucial.

The Drug Registry also leverages international standards such as SNOMED CT to support interoperability and semantic consistency. SNOMED CT is a globally recognized clinical terminology standard used to represent medical concepts in a structured way. Its use can help India’s digital health platforms align with international best practices.

What the Drug Registry Contains

The Drug Registry currently includes standardized drug codes across three major categories:

Generic or clinical drugs.

Branded medicines.

Substances.

According to the launch details, the registry currently comprises more than 123,000 branded drugs, more than 10,000 generic drugs and more than 29,000 substances.

This wide coverage is important because India has a large pharmaceutical market with thousands of branded formulations, generic medicines and active substances. A registry that covers only generic names would be useful, but limited. A registry that also includes brand names, substances and manufacturer-linked information becomes much more practical for real-world healthcare use.

Doctors, hospitals, pharmacies, health-tech platforms and insurance systems often deal with both generic and branded drug references. By supporting multiple levels of identification, the Drug Registry can serve a wider range of users.

How Users Can Search the Registry

The platform allows users to search and identify drugs using multiple parameters.

Users can search by generic name.

They can search by brand name.

They can search by substance.

They can search by manufacturer.

This search flexibility is important because different stakeholders look for medicine information in different ways. A doctor may think in terms of generic drug or therapeutic substance. A patient may know only the brand name printed on the strip. A hospital pharmacy may search by manufacturer or product label. A digital platform may need to map brand and generic information together.

By allowing search across these fields, the Drug Registry can reduce confusion and improve access to verified drug information.

Role in E-Prescriptions

One of the most important applications of the Drug Registry will be e-prescriptions. As digital prescriptions expand, medicine names must be entered accurately and consistently.

Without standardization, a doctor may type a brand name in one way, a pharmacy may interpret it differently and a hospital system may store it under another name. This can create prescription errors, duplication and difficulty in tracking medication history.

With the Drug Registry, e-prescription platforms can use standardized drug codes. This can make prescriptions clearer, improve medicine substitution logic, support generic-brand mapping and reduce data-entry errors.

For patients, this means a more reliable medicine record. For doctors, it means better prescription support. For pharmacists, it means easier identification and dispensing. For digital health platforms, it means cleaner and more interoperable data.

Role in Hospital Management Information Systems

Hospital Management Information Systems are central to modern healthcare delivery. They handle patient registration, consultations, prescriptions, pharmacy stock, billing, laboratory orders, discharge summaries and insurance documentation.

Medicine data flows through almost every part of a hospital system. If drug names are inconsistent, hospitals face problems in inventory management, billing, medicine reconciliation, patient records and clinical audits.

The Drug Registry can help HMIS platforms standardize their medicine master data. Instead of each hospital maintaining its own isolated medicine list, systems can integrate with a verified national drug database.

This can improve hospital efficiency, reduce duplication, support clinical decision-making and make records more reliable.

Role in Pharmacy and Supply Chain Management

The Drug Registry can also improve pharmacy and supply chain operations. Medicine supply chains involve manufacturers, distributors, hospitals, retail pharmacies, government procurement agencies and public health programmes.

A standardized drug database can help improve tracking, procurement, stock management and distribution. If medicine information is stored in a consistent format, it becomes easier to compare demand, identify shortages, monitor supplies and avoid duplication.

This is especially useful in public health systems, where large-scale procurement and distribution depend on accurate medicine identification. For essential medicines, vaccines, programme drugs and emergency supplies, clean data can improve planning and availability.

Role in Clinical Decision-Making

Clinical decisions depend on accurate medicine information. Doctors need to know what medicine a patient is taking, its generic composition, possible substitutions, therapeutic category and interaction risks.

A standardized Drug Registry can support clinical decision support systems in the future. It can help digital platforms identify medicines more accurately, link brand names to generic substances and create more reliable medication histories.

This can be especially useful for patients who visit multiple doctors or hospitals. If their medication records are stored using standardized codes, continuity of care becomes easier. A doctor in one hospital can better understand a prescription issued elsewhere, provided the systems are connected through ABDM-compliant platforms.

Benefits for Citizens

For citizens, the Drug Registry can bring greater transparency and trust in medicine information. Patients often know medicines by brand names, while doctors and healthcare systems may use generic names. A standardized registry can help bridge this gap.

As more applications integrate with the Drug Registry, citizens may benefit from clearer medicine information, better digital prescriptions, more reliable health records and improved continuity of care.

The registry can also reduce confusion created by similar-sounding medicine names, multiple brands for the same molecule and inconsistent spelling across systems.

Benefits for Doctors

Doctors can benefit from more accurate e-prescribing tools. Standardized drug data can reduce typing errors, improve medicine selection and support structured digital prescriptions.

A reliable registry can also help doctor-facing applications provide better search, generic-brand mapping and prescription templates. Over time, this can support safer prescribing practices and more efficient clinical workflows.

Benefits for Hospitals and Clinics

Hospitals and clinics can use the Drug Registry to clean and standardize their medicine databases. This can improve pharmacy operations, billing, discharge summaries, medication history and internal audits.

Small clinics using ABDM-compliant tools can also benefit because they may not have the resources to build and maintain large drug databases independently. A national registry gives them access to structured medicine information through digital integration.

Benefits for Health-Tech Platforms

India’s health-tech ecosystem includes telemedicine platforms, e-pharmacies, electronic medical record providers, health apps, insurance platforms and hospital software vendors. For these platforms, standardized medicine data is a foundational requirement.

The Drug Registry provides open APIs for integration. This allows digital health products to connect with a verified and standardized drug database rather than building isolated and inconsistent medicine lists.

For developers, this can reduce duplication and improve compliance with ABDM standards. For users, it can create a more consistent experience across apps and platforms.

Benefits for Regulators and Policymakers

For regulators and policymakers, standardized medicine data can improve visibility across the healthcare ecosystem. It can support better analysis of medicine usage, procurement trends, prescription patterns and supply chain needs.

A verified drug database can also help in regulatory monitoring, public health planning and policy design. Over time, better medicine data can support decisions related to essential medicines, drug availability and healthcare resource planning.

Open APIs and Interoperability

A major feature of the Drug Registry is its open API-based integration model. APIs allow different software systems to communicate with the registry and retrieve standardized drug information.

This is essential because India’s healthcare ecosystem is highly diverse. Large corporate hospitals, public hospitals, small clinics, digital health start-ups, insurance platforms and pharmacy systems all use different software tools. Without APIs, a central registry would remain isolated. With APIs, the registry can become part of day-to-day digital healthcare operations.

The open API model also supports innovation. Developers can build ABDM-compliant applications that use verified medicine data from the registry, improving trust and consistency across platforms.

Global Standards and Semantic Consistency

The use of international standards such as SNOMED CT is a key technical strength. Interoperability in healthcare is not only about sending data from one platform to another. It is about ensuring that both systems understand the data in the same way.

For example, if a drug substance, formulation or brand is represented in one system, another system should be able to interpret it correctly. Semantic consistency helps prevent misinterpretation.

By aligning with global terminology standards, the Drug Registry can support more reliable data exchange and future integration with advanced digital health tools.

Why Medicine Data Standardization Is Urgent

India’s healthcare system is vast and diverse. It includes public hospitals, private hospitals, clinics, pharmacies, laboratories, insurance platforms, government health programmes and digital health start-ups.

In such a large ecosystem, inconsistent medicine data can create multiple problems. A medicine may be duplicated under different names. A brand may be mapped incorrectly to a generic substance. A prescription may become difficult to interpret across systems. A patient’s medication history may remain fragmented.

As healthcare becomes more digital, these inconsistencies become more visible and more damaging. Digital health requires common data standards. The Drug Registry addresses this foundational requirement.

Link With India’s Digital Public Infrastructure

The Drug Registry is part of India’s broader approach to digital public infrastructure. Just as Aadhaar created a digital identity layer and UPI created a digital payments layer, ABDM is creating a digital health layer.

Within this health layer, registries play a central role. They provide verified and standardized reference points. The Drug Registry adds the medicine-data layer to this architecture.

This is important because healthcare depends on trusted data. A connected health ecosystem cannot function efficiently if medicines, doctors, facilities and patient records are represented differently across platforms.

Potential Impact on Patient Safety

Patient safety can improve when medicine information is standardized. Clear drug identification reduces the risk of confusion between similar names. Structured prescription data can help avoid duplication. Better medication histories can help doctors review what a patient is already taking.

In the future, standardized drug data can also support alerts for allergies, drug interactions, dosage checks and contraindications when integrated with clinical decision-support systems.

The Drug Registry is therefore not only a database. It can become a patient-safety tool when integrated properly into healthcare workflows.

Potential Impact on Generic Medicines

The registry includes both generic drugs and branded medicines. This can help improve understanding of the relationship between brand names and generic substances.

India has a strong generic medicines sector. A standardized registry can support generic prescribing, brand-generic mapping and better transparency in medicine identification.

For citizens, this can gradually make medicine information easier to understand. For doctors and pharmacists, it can support clearer substitution and dispensing workflows, subject to applicable rules and clinical judgment.

Importance for Continuity of Care

Continuity of care is one of the biggest advantages of digital health. A patient may receive treatment from a primary clinic, then visit a specialist, then get admitted to a hospital, and later continue treatment through follow-up consultations.

If medicine information is recorded differently at every stage, the patient’s medication history becomes fragmented. The Drug Registry can help solve this by allowing medicines to be recorded in a standardized format across systems.

This is especially important for chronic disease management. Patients with diabetes, hypertension, heart disease, kidney disease, asthma or other long-term conditions often take multiple medicines over long periods. Accurate medicine records can improve follow-up care and reduce treatment errors.

Challenges Ahead

The launch of the Drug Registry is a major step, but its success will depend on adoption and integration.

Hospitals, clinics, pharmacies and health-tech platforms must integrate the registry into their systems.

Medicine databases must be updated regularly.

Manufacturers and regulatory databases must remain aligned.

Users must be trained to use standardized medicine information.

Legacy hospital systems may need technical upgrades.

Small healthcare providers may require simple ABDM-compliant tools.

The registry must remain current as new medicines, brands and formulations enter the market.

These challenges are natural for any large national digital health infrastructure. The key will be continuous updating, strong governance, easy APIs and practical adoption by healthcare providers.

Strategic Significance

The Drug Registry strengthens the digital foundation of India’s healthcare system. It brings medicine data into the same structured architecture that ABDM is building for individuals, healthcare professionals and health facilities.

This matters because medicine information is central to almost every healthcare transaction. By standardizing drug data, India can improve e-prescriptions, digital records, hospital systems, pharmacy operations, supply chain visibility, insurance processes and public health analytics.

The initiative also supports transparency and trust. A verified national database reduces dependence on fragmented private lists and inconsistent local databases.

Key Facts

The Drug Registry was launched by Union Health Minister Shri Jagat Prakash Nadda.

It has been conceptualized under the Ayushman Bharat Digital Mission.

It is designed as a unified and standardized digital platform for drug-related information.

It aims to serve as a single source of truth for medicines in India.

It has been developed with the Central Drugs Standard Control Organization and the National Resource Centre for EHR Standards, Pune.

It uses international standards such as SNOMED CT.

It includes standardized drug codes for generic drugs, branded medicines and substances.

It currently includes more than 123,000 branded drugs.

It currently includes more than 10,000 generic drugs.

It currently includes more than 29,000 substances.

Users can search by generic name, brand name, substance and manufacturer.

It is designed to integrate with HMIS platforms, e-prescription systems, doctor-facing applications and ABDM-compliant digital health solutions.

It provides open APIs for integration.

Conclusion

The launch of the Drug Registry marks an important milestone in India’s digital health journey. By creating a standardized and verified national database for medicines, the government is addressing one of the most basic but critical problems in healthcare data: inconsistent drug information.

The registry can improve e-prescriptions, reduce data-entry errors, support hospital systems, strengthen pharmacy workflows, improve continuity of care and enable better interoperability across digital health platforms.

Its importance will grow as more hospitals, clinics, pharmacies, insurance systems and health applications become ABDM-compliant. The Drug Registry gives India’s healthcare ecosystem a common medicine language. This can make digital healthcare more accurate, transparent, connected and patient-friendly.

In simple terms, the Drug Registry is not just a database of medicines. It is a digital health infrastructure layer that can help doctors prescribe better, hospitals manage better, pharmacies identify better, platforms integrate better and patients receive safer, more reliable care.

Source: PIB